Page last updated: 2024-08-17

ficusin and Cancer of Skin

ficusin has been researched along with Cancer of Skin in 50 studies

Research

Studies (50)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (14.00)	18.7374
1990's	5 (10.00)	18.2507
2000's	17 (34.00)	29.6817
2010's	13 (26.00)	24.3611
2020's	8 (16.00)	2.80

Authors

Authors	Studies
Ishii, T; Masuda, K; Mori, K; Nakahashi, K; Nihira, K; Suzuki, M	1
Brandozzi, G; Bugatti, L; Campanati, A; Filosa, G; Giacchetti, A; Giantomassi, F; Goteri, G; Molinelli, E; Morsia, E; Mozzicafreddo, G; Offidani, AM; Olivieri, A; Rupoli, S; Serresi, S; Simonacci, M; Torre, E	1
Vieyra-Garcia, P; Wolf, P	2
Heshmati, F	1
Kluwig, D; Yazdi, AS	1
Arase, N; Fujimoto, M; Kiyohara, E; Nakagawa, Y; Nakanishi, Y; Tanemura, A; Tonomura, K	1
Duvic, M; Morris, L; Reddy, S; Tran, J; Vu, A	1
Furuhashi, T; Ikumi, K; Kubo, R; Masuda, H; Matsumoto, K; Morita, A; Muramatsu, S; Nakamura, M; Nishida, E; Shintani, Y; Watanabe, S; Yamazaki, S	1
Ikumi, K; Kato, H; Morita, A; Nakamura, M; Sakurai, M	1
Dawe, RS	1
Boix-Vilanova, J; Corral-Magaña, O; Escalas, J; Martin-Santiago, A	1
Ibbotson, S	1
Fassihi, H; Phan, K; Ramachandran, V; Sebaratnam, DF	1
Guitart, J	1
Cowper, S; Girardi, M; Huang, J; Moss, J	1
Beyer, M; Erdmann, R; Humme, D; Nast, A; Vandersee, S	1
Abeni, D; Didona, B; Paradisi, A; Russo, N; Sobrino, L; Tabolli, S	1
Wolf, P	1
Hoppe, R; Prince, HM; Whittaker, S	1
Ibuki, Y; Toyooka, T	1
Beissert, S; Hensen, P; Hüsken, AC; Loquai, C; Luger, TA; Nashan, D; Schiller, M; Sunderkötter, C; Tsianakas, A	1
Bäck, B; Cerroni, L; Kerl, H; Kreimer-Erlacher, H; Seidl, H; Wolf, P	1
Junkins-Hopkins, JM; McGinnis, KS; Rook, AH; Shapiro, M; Vittorio, CC	1
Aydemir, EH; Engin, B; Oguz, O	1
Balavoine, M; Candon-Kerlau, S; Clot, J; Dereure, O; Eliaou, JF; Guilhou, JJ; Salles, MT	1
HOPKINS, CE	1
BLACK, GL; GARRETT, H; GRIFFIN, AC; HOPKINS, CE; MACDONALD, EJ; SMITH, L	1
BELISARIO, JC; DAVIS, CT; HOPKINS, CE; MACDONALD, EJ	1
Bäck, B; Kerl, H; Kreimer-Erlacher, H; Seidl, H; Soyer, HP; Wolf, P	1
Lundin, J; Osterborg, A	1
McKenna, KE	1
Lim, JL; Stern, RS	1
Bagot, M; Dreno, B; Dummer, R; Foss, F	1
Gupta, S; Mahendra, A	1
Geskin, L	1
Heitzer, E; Wolf, P	1
Fischer, T; Groth, O; Molin, L; Nordentoft, A; Thomsen, K; Volden, G; Zachariae, H	1
Autier, P; Bollaerts, A; Cesarini, JP; Doré, JF; Gefeller, O; Koelmel, KF; Lejeune, F; Liabeuf, A; Lienard, D; Schifflers, E	1
Fivenson, DP; Saed, GM	1
Elenitsas, R; Gasparro, FP; Rook, AH; Vowels, BR; Yoo, EK	1
Liebman, EJ; Stern, RS; Väkevä, L	1
Dybdahl, M; Frentz, G; Nexø, BA; Vogel, U; Wallin, H	1
Almagro, M; del Pozo, J; Fonseca, E; García-Silva, J; Martínez, W; Vázquez, J; Yebra-Pimentel, MT	1
Bäck, B; Höfler, G; Kerl, H; Kreimer-Erlacher, H; Seidl, H; Soyer, HP; Wolf, P	1
Katz, KA; Marcil, I; Stern, RS	1
Bagheri, S; Nichols, K; Stern, RS	1
Bensoussan, D; Berretti, B; Grupper, CH; Schnitzler, L	1
Carruthers, JA; Warin, AP	1

Reviews

8 review(s) available for ficusin and Cancer of Skin

Article	Year
Drug and chemical induced photosensitivity from a clinical perspective. Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2018, Dec-05, Volume: 17, Issue:12 Topics: Carcinoma, Squamous Cell; Erythema; Ficusin; Humans; Photosensitivity Disorders; Photosensitizing Agents; Psoriasis; Skin Neoplasms; Sunscreening Agents; Ultraviolet Rays	2018
Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis. JAMA dermatology, 2019, 03-01, Volume: 155, Issue:3 Topics: Aged; Female; Ficusin; Humans; Male; Middle Aged; Mycosis Fungoides; Prognosis; PUVA Therapy; Skin Neoplasms; Treatment Outcome; Ultraviolet Therapy	2019
Systematic review of combination therapies for mycosis fungoides. Cancer treatment reviews, 2014, Volume: 40, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Combined Modality Therapy; Deoxycytidine; Ficusin; Gemcitabine; Humans; Hydroxamic Acids; Interferon-alpha; Methotrexate; Mycosis Fungoides; Phototherapy; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes; Vorinostat	2014
Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma. Archives of dermatology, 2003, Volume: 139, Issue:6 Topics: Aged; Anticarcinogenic Agents; Bexarotene; Drug Therapy, Combination; Female; Ficusin; Humans; Male; Middle Aged; Photosensitizing Agents; PUVA Therapy; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes	2003
Therapy for mycosis fungoides. Current treatment options in oncology, 2004, Volume: 5, Issue:3 Topics: Combined Modality Therapy; Ficusin; Humans; Interferon-alpha; Mycosis Fungoides; Neoplasm Staging; Photosensitizing Agents; Skin Neoplasms; Ultraviolet Therapy	2004
Iatrogenic skin cancer: induction by psoralen/ultraviolet A and immunosuppression of organ transplant recipients. Photodermatology, photoimmunology & photomedicine, 2004, Volume: 20, Issue:6 Topics: Ficusin; Humans; Iatrogenic Disease; Immunocompromised Host; Immunosuppressive Agents; Organ Transplantation; Photosensitizing Agents; PUVA Therapy; Skin Neoplasms	2004
ECP versus PUVA for the treatment of cutaneous T-cell lymphoma. Skin therapy letter, 2007, Volume: 12, Issue:5 Topics: Ficusin; Humans; Lymphoma, T-Cell, Cutaneous; Photopheresis; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome; Ultraviolet Therapy	2007
Editorial: Photochemotherapy in psoriasis. Clinical and experimental dermatology, 1976, Volume: 1, Issue:2 Topics: Animals; Cataract; Coumarins; Ficusin; Furocoumarins; Humans; Methoxsalen; Mice; Nausea; Pruritus; Psoriasis; Skin Neoplasms; Ultraviolet Therapy	1976

Trials

3 trial(s) available for ficusin and Cancer of Skin

Article	Year
Correlations between clinical, histologic, blood, and skin polymerase chain reaction outcome in patients treated for mycosis fungoides. The Journal of investigative dermatology, 2003, Volume: 121, Issue:3 Topics: Adult; Aged; Female; Ficusin; Gene Rearrangement, T-Lymphocyte; Humans; Male; Middle Aged; Mycosis Fungoides; Photosensitizing Agents; Polymerase Chain Reaction; Predictive Value of Tests; Receptors, Antigen, T-Cell; Skin Neoplasms; Treatment Outcome; Ultraviolet Therapy	2003
Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. Journal of the National Cancer Institute, 1998, Sep-02, Volume: 90, Issue:17 Topics: Administration, Oral; Adult; Analysis of Variance; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Ficusin; Follow-Up Studies; Humans; Male; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Psoriasis; Risk Factors; Skin Neoplasms; Ultraviolet Rays	1998
Low DNA repair is a risk factor in skin carcinogenesis: a study of basal cell carcinoma in psoriasis patients. Mutation research, 1999, Jan-26, Volume: 433, Issue:1 Topics: Adult; Age Factors; Carcinoma, Basal Cell; Denmark; DNA Repair; DNA, Neoplasm; Female; Ficusin; Humans; Lymphocytes; Male; Middle Aged; Psoriasis; Risk Factors; Skin Neoplasms; Statistics, Nonparametric; Transfection; Tumor Cells, Cultured; Ultraviolet Therapy	1999

Other Studies

39 other study(ies) available for ficusin and Cancer of Skin

Article	Year
A novel mouse model of cutaneous T-cell lymphoma revealed the combined effect of mogamulizumab with psoralen and ultraviolet a therapy. Experimental dermatology, 2022, Volume: 31, Issue:11 Topics: Animals; Ficusin; Lymphoma, T-Cell, Cutaneous; Methoxsalen; Mice; Mycosis Fungoides; PUVA Therapy; Skin Neoplasms; Ultraviolet Therapy	2022
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints. Dermatologic therapy, 2022, Volume: 35, Issue:10 Topics: Ficusin; Humans; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Neoplasm Recurrence, Local; Prognosis; PUVA Therapy; Skin Neoplasms; Treatment Outcome	2022
Explanation of Additional Errors in Report of Trial of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment. JAMA dermatology, 2019, 10-01, Volume: 155, Issue:10 Topics: Administration, Oral; Ficusin; Humans; Mycosis Fungoides; PUVA Therapy; Skin Neoplasms	2019
[The past, present and future of extracorporeal photopheresis]. Annales de dermatologie et de venereologie, 2020, Volume: 147, Issue:2 Topics: Ficusin; History, 20th Century; History, Ancient; Humans; Immune Tolerance; Immunity, Cellular; Lymphoma, T-Cell, Cutaneous; Photopheresis; Photosensitizing Agents; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory	2020
[Low-frequency, low-dose oral psoralen-UV-A therapy for mycosis fungoides]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2020, Volume: 71, Issue:1 Topics: Ficusin; Humans; Mycosis Fungoides; PUVA Therapy; Skin Neoplasms; Treatment Outcome	2020
Use of a combination of oral psoralen, ultraviolet A and interferon-γ for the treatment of mycosis fungoides during pregnancy, which probably evoked CD8 The Journal of dermatology, 2021, Volume: 48, Issue:1 Topics: Adult; CD8-Positive T-Lymphocytes; Female; Ficusin; Humans; Interferon-gamma; Mycosis Fungoides; Pregnancy; Skin Neoplasms; Ultraviolet Therapy	2021
Anaphylaxis following administration of extracorporeal photopheresis for cutaneous T cell lymphoma. Dermatology online journal, 2020, Sep-15, Volume: 26, Issue:9 Topics: Adult; Anaphylaxis; Anticoagulants; Disinfectants; Ethylene Oxide; Female; Ficusin; Glucocorticoids; Heparin; Histamine Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Photopheresis; Photosensitizing Agents; Skin Neoplasms	2020
Efficacy of bath-psoralen and ultraviolet A therapy for mycosis fungoides - retrospective analysis of 62 cases. The Journal of dermatology, 2022, Volume: 49, Issue:2 Topics: Ficusin; Humans; Mycosis Fungoides; PUVA Therapy; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Ultraviolet Therapy	2022
Dermoscopic findings of psoralen and ultraviolet A therapy lentigines resembling melanoma in a patient with mycosis fungoides. The Journal of dermatology, 2021, Volume: 48, Issue:11 Topics: Ficusin; Humans; Lentigo; Melanoma; Mycosis Fungoides; PUVA Therapy; Skin Neoplasms; Ultraviolet Therapy	2021
Psoralen-ultraviolet A maintenance in mycosis fungoides: the underlying question. The British journal of dermatology, 2017, Volume: 177, Issue:2 Topics: Ficusin; Humans; Mycosis Fungoides; PUVA Therapy; Skin Neoplasms	2017
Maintenance therapy with psoralen-ultraviolet A for mycosis fungoides: in the absence of evidence sitting on the fence is appropriate. The British journal of dermatology, 2017, Volume: 177, Issue:2 Topics: Ficusin; Humans; Mycosis Fungoides; PUVA Therapy; Skin Neoplasms	2017
Folliculotropic mycosis fungoides in a pediatric patient with response to psoralen-ultraviolet A phototherapy. Photodermatology, photoimmunology & photomedicine, 2019, Volume: 35, Issue:1 Topics: Adolescent; Ficusin; Humans; Male; Mycosis Fungoides; PUVA Therapy; Skin Neoplasms; Ultraviolet Rays	2019
Psoralen Plus UV-A Therapy in the 21st Century: Use It or Lose It. JAMA dermatology, 2019, 05-01, Volume: 155, Issue:5 Topics: Ficusin; Furocoumarins; Humans; Mycosis Fungoides; PUVA Therapy; Skin Neoplasms	2019
Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides. Journal of drugs in dermatology : JDD, 2013, Volume: 12, Issue:4 Topics: Administration, Oral; Anticarcinogenic Agents; Bexarotene; Combined Modality Therapy; Ficusin; Follow-Up Studies; Humans; Lasers, Excimer; Male; Middle Aged; Mycosis Fungoides; Photosensitizing Agents; PUVA Therapy; Skin Neoplasms; Tetrahydronaphthalenes	2013
Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:6 Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Female; Ficusin; Humans; Incidence; Logistic Models; Male; Melanoma; Middle Aged; Multivariate Analysis; Photosensitizing Agents; Risk; Risk Factors; Skin Neoplasms; Ultraviolet Therapy; Vitiligo	2014
Psoralen-ultraviolet A endures as one of the most powerful treatments in dermatology: reinforcement of this 'triple-product therapy' by the 2016 British guidelines. The British journal of dermatology, 2016, Volume: 174, Issue:1 Topics: Dermatology; Ficusin; Humans; PUVA Therapy; Skin Neoplasms	2016
How I treat mycosis fungoides and Sézary syndrome. Blood, 2016, 06-23, Volume: 127, Issue:25 Topics: Ficusin; Humans; Male; Middle Aged; Mycosis Fungoides; Neoplasm Staging; Photopheresis; Photosensitizing Agents; Sezary Syndrome; Skin Neoplasms	2016
Histone deacetylase inhibitor sodium butyrate enhances the cell killing effect of psoralen plus UVA by attenuating nucleotide excision repair. Cancer research, 2009, Apr-15, Volume: 69, Issue:8 Topics: Apoptosis; Butyrates; Carcinoma, Squamous Cell; Cell Line, Tumor; DNA Repair; Drug Synergism; Enzyme Inhibitors; Ficusin; Histone Deacetylase Inhibitors; Humans; Melanoma; Photosensitizing Agents; PUVA Therapy; Skin Neoplasms	2009
Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphoma. Journal of the European Academy of Dermatology and Venereology : JEADV, 2012, Volume: 26, Issue:1 Topics: Adult; Aged; Female; Ficusin; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, T-Cell; Male; Middle Aged; Photosensitizing Agents; Polyethylene Glycols; PUVA Therapy; Recombinant Proteins; Retrospective Studies; Skin Neoplasms	2012
High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients. The Journal of investigative dermatology, 2003, Volume: 120, Issue:4 Topics: Adult; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; DNA Fingerprinting; DNA Mutational Analysis; Female; Ficusin; Humans; Male; Middle Aged; Mutation; Photosensitizing Agents; Polymorphism, Single-Stranded Conformational; Psoriasis; PUVA Therapy; Skin Neoplasms; Tumor Suppressor Protein p14ARF	2003
The influence of psoralen + ultraviolet A treatment on the duration of remission and prognosis in mycosis fungoides. Journal of the European Academy of Dermatology and Venereology : JEADV, 2003, Volume: 17, Issue:4 Topics: Adult; Cohort Studies; Evaluation Studies as Topic; Female; Ficusin; Follow-Up Studies; Humans; Male; Middle Aged; Mycosis Fungoides; PUVA Therapy; Risk Assessment; Severity of Illness Index; Skin Neoplasms; Treatment Outcome	2003
Psoralen prophylaxis against skin cancer: progress of field trials. The Journal of investigative dermatology, 1959, Volume: 32, Issue:2, Part 2 Topics: Coumarins; Ficusin; Furans; Humans; Skin Neoplasms	1959
PSORALEN PROPHYLAXIS AGAINST SKIN CANCER: REPORT OF CLINICAL TRIAL I. The Journal of investigative dermatology, 1963, Volume: 41 Topics: Ficusin; Geriatrics; Methoxsalen; Neoplasms; Skin Neoplasms; Sunburn; Toxicology	1963
PSORALEN PROPHYLAXIS AGAINST SKIN CANCER: REPORT OF CLINICAL TRIAL II. The Journal of investigative dermatology, 1963, Volume: 41 Topics: Ficusin; Humans; Methoxsalen; Neoplasms; Skin Neoplasms; Sunburn; Toxicology	1963
The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients. The Journal of investigative dermatology, 2004, Volume: 122, Issue:1 Topics: Adult; Carcinoma, Squamous Cell; Female; Ficusin; Genes, p53; Genes, ras; Humans; Keratosis; Male; Middle Aged; Mutation, Missense; Neoplasms, Radiation-Induced; Psoriasis; PUVA Therapy; Radiation-Sensitizing Agents; Risk Factors; Skin Neoplasms; Ultraviolet Rays	2004
High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. The Journal of investigative dermatology, 2005, Volume: 124, Issue:3 Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Environmental Exposure; Female; Ficusin; Follow-Up Studies; Humans; Incidence; Male; Photosensitizing Agents; Psoriasis; Risk Factors; Skin Neoplasms; Ultraviolet Rays	2005
Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms. Seminars in oncology, 2006, Volume: 33, Issue:1 Suppl 3 Topics: Aged; Antineoplastic Agents; Carmustine; Combined Modality Therapy; Dermatitis, Exfoliative; Erythema Nodosum; Female; Ficusin; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Phototherapy; PUVA Therapy; Sezary Syndrome; Skin Neoplasms	2006
Inverse halo nevus. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2006, Volume: 32, Issue:6 Topics: Adult; Diagnosis, Differential; Female; Ficusin; Follow-Up Studies; Glucocorticoids; Head and Neck Neoplasms; Humans; Nevus, Pigmented; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Skin Transplantation	2006
Nonmonoclonal PTCH gene mutations in psoralen plus UVA-associated basal cell carcinomas. The Journal of investigative dermatology, 2008, Volume: 128, Issue:3 Topics: Carcinoma, Basal Cell; Ficusin; Humans; Mutation; Patched Receptors; Patched-1 Receptor; Photosensitizing Agents; Prevalence; Receptors, Cell Surface; Skin Neoplasms; Ultraviolet Rays	2008
Aspects of the treatment of mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Study Group. Cutis, 1980, Volume: 25, Issue:2 Topics: Bleomycin; Electrons; Ficusin; Humans; Mechlorethamine; Methotrexate; Mycosis Fungoides; Neoplasm Staging; Photochemotherapy; Skin Neoplasms; Transfer Factor; Ultraviolet Therapy	1980
Melanoma and use of sunscreens: an Eortc case-control study in Germany, Belgium and France. The EORTC Melanoma Cooperative Group. International journal of cancer, 1995, Jun-09, Volume: 61, Issue:6 Topics: Adult; Belgium; Case-Control Studies; Cosmetics; Female; Ficusin; France; Germany; Humans; Male; Melanoma; Middle Aged; Regression Analysis; Risk; Skin Neoplasms; Sunlight; Sunscreening Agents; White People	1995
Quantitation of interferon gamma mRNA levels in psoralen/UVA-treated HUT-78 cells by competitive PCR. Biochemical and biophysical research communications, 1994, Sep-15, Volume: 203, Issue:2 Topics: Base Sequence; Binding, Competitive; Ficusin; Humans; Interferon-gamma; Molecular Sequence Data; Polymerase Chain Reaction; RNA, Messenger; Sezary Syndrome; Skin Neoplasms; Tumor Cells, Cultured; Ultraviolet Rays	1994
Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. The Journal of investigative dermatology, 1996, Volume: 107, Issue:2 Topics: Apoptosis; DNA; Dose-Response Relationship, Radiation; Ficusin; Flow Cytometry; Fluorescent Dyes; Humans; Kinetics; Lymphocyte Subsets; Lymphoma, T-Cell; Major Histocompatibility Complex; Monocytes; Photopheresis; PUVA Therapy; Skin Neoplasms; Ultraviolet Rays	1996
Cutaneous T-cell lymphoma presenting as disseminated, pigmented, purpura-like eruption. International journal of dermatology, 2001, Volume: 40, Issue:2 Topics: Ficusin; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; PUVA Therapy; Skin; Skin Neoplasms	2001
Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis. The Journal of investigative dermatology, 2001, Volume: 117, Issue:2 Topics: Adult; Aged; Carcinoma, Basal Cell; Female; Ficusin; Humans; Incidence; Male; Middle Aged; Photosensitizing Agents; Point Mutation; Polymorphism, Single-Stranded Conformational; Psoriasis; PUVA Therapy; Skin Neoplasms; Tumor Suppressor Protein p53; Ultraviolet Rays	2001
Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients. The Journal of investigative dermatology, 2002, Volume: 118, Issue:6 Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Female; Ficusin; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Neoplasms, Second Primary; Photosensitizing Agents; Psoriasis; Risk Factors; Skin Neoplasms; Survival Analysis; Ultraviolet Rays	2002
The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis. Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:1 Topics: Adult; Age Distribution; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Ficusin; Genital Neoplasms, Male; Genitalia, Male; Humans; Incidence; Male; Middle Aged; Probability; Prognosis; Prospective Studies; Psoriasis; PUVA Therapy; Risk Factors; Skin Neoplasms	2002
[Treatment of mycosis fungoides by PUVAtherapy. Report on 18 cases (author's transl)]. Annales de dermatologie et de venereologie, 1978, Volume: 105, Issue:3 Topics: Aged; Coumarins; Female; Ficusin; Humans; Male; Middle Aged; Mycosis Fungoides; Photochemotherapy; Skin Neoplasms; Ultraviolet Therapy	1978
Mycosis fungoides responding to photopheresis. Oncology (Williston Park, N.Y.), 1989, Volume: 3, Issue:7 Topics: Ficusin; Furocoumarins; Humans; Mycosis Fungoides; Neoplasm Staging; Photochemotherapy; Skin Neoplasms	1989